Dr. Farzin's treatment philosophy centers on the profound connection between mind and body. He emphasizes the therapeutic potential of psychedelics in facilitating somatic awareness, enabling patients to access and process deep-seated traumas stored in the body. His approach underscores the importance of accepting and working through all emotions, including sadness, as a path to healing and transformation. This philosophy is reflected in his use of psychedelics to manifest hidden traumas and guide patients towards acceptance and understanding of their conditions.

He is a key figure in the advancement of legal psychedelic-assisted psychotherapy in Canada, notably through his work with Health Canada to obtain legal access for psilocybin therapy. His efforts have led to groundbreaking treatments and clinical practices, including the first series of patients treated with ketamine in Quebec's public healthcare system. He has also contributed to significant research on the use of psychedelics for end-of-life distress and other conditions.

In addition to his clinical and research achievements, Dr. Farzin co-founded Injoy (formerly Phyla), a digital health tool that uses AI to connect diet, lifestyle, and microbiome health. His commitment to holistic health is further demonstrated by his involvement in various non-profit organizations and his dedication to improving healthcare access for Indigenous and remote communities in Canada.

Dr. Farzin's work is deeply inspired by his personal experiences and his passion for integrating ancient wisdom with modern science to foster healing and well-being at all stages of life. His treatment philosophy continues to shape his practice, offering hope and compassion to those navigating the complexities of terminal illness and existential distress.